IRIS
OLIVIERI, Attilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.051
EU - Europa 9.413
AS - Asia 9.013
SA - Sud America 2.722
AF - Africa 534
Continente sconosciuto - Info sul continente non disponibili 57
OC - Oceania 11
AN - Antartide 1
Totale 37.802
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.748
SG - Singapore 2.571
BR - Brasile 2.111
VN - Vietnam 2.109
RU - Federazione Russa 1.689
UA - Ucraina 1.496
CN - Cina 1.281
IT - Italia 1.060
IE - Irlanda 951
HK - Hong Kong 906
DE - Germania 889
SE - Svezia 832
TR - Turchia 760
FI - Finlandia 605
DK - Danimarca 599
FR - Francia 570
KR - Corea 322
GB - Regno Unito 319
IN - India 238
AR - Argentina 228
CI - Costa d'Avorio 180
BD - Bangladesh 158
CA - Canada 137
MA - Marocco 125
MX - Messico 115
ID - Indonesia 100
NL - Olanda 99
EC - Ecuador 90
IQ - Iraq 86
JP - Giappone 86
ZA - Sudafrica 86
CO - Colombia 79
VE - Venezuela 65
PL - Polonia 62
UZ - Uzbekistan 56
EU - Europa 54
ES - Italia 51
CL - Cile 45
PY - Paraguay 45
PK - Pakistan 42
AT - Austria 41
TN - Tunisia 40
PH - Filippine 36
EG - Egitto 28
SA - Arabia Saudita 27
PE - Perù 26
KZ - Kazakistan 25
BE - Belgio 24
DZ - Algeria 24
JO - Giordania 24
MY - Malesia 24
AE - Emirati Arabi Uniti 22
UY - Uruguay 19
LT - Lituania 16
CZ - Repubblica Ceca 15
TH - Thailandia 15
IL - Israele 14
KE - Kenya 13
OM - Oman 13
BO - Bolivia 12
NP - Nepal 12
RS - Serbia 12
AZ - Azerbaigian 11
RO - Romania 11
AL - Albania 10
CR - Costa Rica 10
TW - Taiwan 10
LB - Libano 9
AU - Australia 8
CH - Svizzera 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
GR - Grecia 8
PS - Palestinian Territory 8
SN - Senegal 8
BG - Bulgaria 7
HU - Ungheria 7
KG - Kirghizistan 7
KW - Kuwait 7
PA - Panama 7
HN - Honduras 6
IR - Iran 6
MN - Mongolia 6
AO - Angola 5
SY - Repubblica araba siriana 5
GA - Gabon 4
GT - Guatemala 4
HR - Croazia 4
JM - Giamaica 4
MD - Moldavia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BN - Brunei Darussalam 3
BZ - Belize 3
GE - Georgia 3
LU - Lussemburgo 3
LV - Lettonia 3
NO - Norvegia 3
PR - Porto Rico 3
QA - Qatar 3
Totale 37.757
Salva come PNG Salva come JPEG
Città #
Ashburn 2.105
Jacksonville 1.573
Singapore 1.445
Chandler 1.023
Dallas 1.010
Fairfield 945
Dublin 944
Hong Kong 878
Boardman 851
Ho Chi Minh City 709
San Jose 540
Wilmington 525
Hanoi 472
The Dalles 463
Houston 405
New York 375
Woodbridge 364
Lawrence 358
Princeton 358
Seattle 353
Lauterbourg 345
Des Moines 325
San Mateo 321
Moscow 303
Los Angeles 270
Beijing 267
Cambridge 257
Ann Arbor 252
Helsinki 245
Hefei 229
São Paulo 184
Abidjan 180
Chicago 140
San Diego 139
Munich 126
Da Nang 122
Milan 109
Centro 104
Buffalo 102
Orem 93
Haiphong 90
Council Bluffs 76
Turin 73
Ancona 72
London 72
Redmond 70
Guangzhou 61
Rio de Janeiro 58
Shanghai 58
Tokyo 58
Turku 53
Santa Clara 51
Curitiba 50
Rome 50
Salt Lake City 50
Chennai 48
Warsaw 47
Amsterdam 44
Tashkent 44
Denver 42
Hải Dương 42
Johannesburg 42
Pune 42
Belo Horizonte 39
Brooklyn 38
Washington 38
Frankfurt am Main 37
Nuremberg 37
Biên Hòa 36
Stockholm 36
Thái Bình 36
Montreal 35
Toronto 35
Brasília 34
Boston 31
Columbus 31
Guayaquil 31
Venice 31
Phoenix 30
Elk Grove Village 29
Manchester 29
Wuhan 29
Atlanta 28
Campinas 28
Izmir 27
Pianella 27
Poplar 27
Porto 27
San Francisco 26
Baghdad 25
Mumbai 25
Quito 25
Marche 24
Mexico City 24
Thái Nguyên 24
Dhaka 23
Medellín 23
Fortaleza 21
Guarulhos 21
Ninh Bình 21
Totale 22.190
Salva come PNG Salva come JPEG
Nome #
The Time Has Come for Targeted Therapies for AML: Lights and Shadows 378
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease 285
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 219
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 209
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 199
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 186
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 180
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 179
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease 176
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 175
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 173
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 171
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study. 170
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 166
Glial-like differentiation potential of human mature adipocytes 166
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 163
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 160
Application of infrared thermography to determine the correlation between skin temperature and onset of graft versus host disease in patients after bone marrow transplantation: A preliminary study 160
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 158
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 157
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 154
BEEAM (BENDAMUSTINE, ETOPOSIDE, ARA-C, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANT IS SAFE AND EFFECTIVE IN AGGRESSIVE B-CELL NON HODGKIN LYMPHOMA: A PHASE II MULTICENTER STUDY 154
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 154
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 154
[Hodgkin's lymphoma and secondary leukemias]. 153
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 152
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]. 150
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 150
[Autoimmune thrombocytopenic purpura and circulating immune complexes]. 148
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 148
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: A nationwide retrospective survey from Italy 148
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 147
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 147
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 146
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 143
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 142
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 141
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 141
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study 141
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission 141
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 140
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: A survey from the ALWP of the EBMT 140
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 139
[Polyneuropathies associated with lymphoplasmacytic dyscrasias: the clinical and instrumental characteristics of a 38-patient case load]. 139
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 139
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 138
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 138
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 137
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 137
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 137
Plasticity of human dedifferentiated adipocytes toward endothelial cells 136
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 136
A rare case of aCML associated with CNS involvement and with aggressive clinical course 136
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 135
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 134
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 134
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 132
Bone marrow adipocytes support haematopoietic stem cell survival 131
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 130
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 130
Real‐world assessment of treatment patterns and outcomes in patients with relapsed‐refractory multiple myeloma in an Italian haematological tertiary care centre 129
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 129
[Polychemotherapy versus melphalan-prednisone in multiple myeloma]. 128
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation 128
Neurologic Complications IIN 169 Consecutive Allogeneic Stem Cell Transplants: Etiology, Clinical Syndromes and Outcome 128
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 127
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently 127
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 126
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 126
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C 125
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 123
[Beta 2-microglobulin in lymphoproliferative disorders]. 123
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 123
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis 122
[Hairy cell leukemia: therapy with lithium carbonate]. 122
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 122
Molecular and functional characterization of human bone marrow adipocytes 122
History and scientific production of clinica medica and clinica ematologica in ancona 122
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications 122
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 121
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 121
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 121
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside. 120
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 120
Allogeneic Stem Cell Transplantation (Allo-SCT) Following a Reduced-Intensity Conditioning (RIC) Regimen in Relapsed Peripheral T-Cell Lymphomas (PTCL): Results at 4 Year of Median Follow-up 119
A novel homozygous stop-codon mutation in human HFE responsible for nonsense-mediated mRNA decay 119
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 119
Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma 119
Radioimmunotherapy (Y-90-Zevalin (R)) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study 118
A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel 118
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 118
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 118
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 117
Safety and Efficacy of Thiotepa-Based Conditioning Therapy for Allogeneic Transplantation in Acute Myeloid Leukemia - a Survey from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 116
Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. 115
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 115
T Repleted Haploidentical Mismatch Allogeneic Versus Autologous Hematopoietic Stem Cell Transplantation In Adult Patients With Acute Leukemia In Complete Remission (CR): A pair-Matched Analysis From The Acute Leukemia Working Party Of EBMT 115
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 115
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes 114
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 113
Totale 14.347
Salva come PNG Salva come JPEG
Categoria #
all - tutte 180.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 180.775
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021615 0 0 0 0 0 0 0 0 0 0 436 179
2021/20222.695 123 692 35 184 18 91 172 220 137 236 206 581
2022/20233.672 442 395 366 231 213 498 9 162 1.019 16 240 81
2023/20242.592 453 64 136 431 439 402 70 58 16 66 59 398
2024/20255.800 644 525 173 61 170 165 753 170 1.205 450 541 943
2025/202614.738 1.004 1.174 1.413 2.113 1.246 1.044 2.647 1.530 1.251 1.263 53 0
Totale 38.372